Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has expanded its portfolio of sexually transmitted infection (STI) testing options to include the First to Know® Syphilis Test, the first over-the-counter blood test granted market authorization by the U.S. Food & Drug Administration (FDA) that can be performed by both physicians and patients.

QuidelOrtho announced Thursday that its Vitros syphilis assay has received 510(k) clearance from the US Food and Drug Administration and is now available globally.

The US Food and Drug Administration announced on Friday that it has granted de novo marketing authorization to an over-the-counter test for syphilis antibodies manufactured by NowDiagnostics.

Chembio Diagnostics has obtained a CLIA waiver from the US Food and Drug Administration for its DPP HIV-Syphilis System, the firm announced on Friday.

Agena Biosciences and DaRui Biotechnology announced today that Agenas MassArray system has been cleared by the China Food and Drug Administration. The system is a mass spectrometry-based platform that Agena acquired from Sequenom in 2014 for

2016 年参展单位登记表 展位号 单位名称 特 展 T01 深圳市亚辉龙生物科技股份有限公司 Shenzhen YHLO Biotech Co., Ltd. T02 美艾利尔（上海）医疗器械销售有限公司 Alere Shanghai Medical Sales Co., L

2016 年参展单位登记表 展位号 单位名称 特 展 T01 深圳市亚辉龙生物科技股份有限公司 Shenzhen YHLO Biotech Co., Ltd. T02 美艾利尔（上海）医疗器械销售有限公司 Alere Shanghai Medical Sales Co., L